跳至主要内容
临床试验/NCT04177082
NCT04177082已完成1 期

Evaluation of the Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Collagen Cross-linking in Eyes With Corneal Thinning Conditions Using Peschke Riboflavin Solution

Cornea Associates of Texas1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2020年1月10日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
200
试验地点
1
主要终点
K-Max

研究概览

简要总结

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Collagen Cross-linking in Eyes With Corneal Thinning Conditions

详细描述

Patients with progressive keratoconus, pellucid marginal degeneration, or at risk for post-refractive corneal ectasia will be recruited and undergo epithelial-on corneal crosslinking with the Peschke PXL-330 system using pulsed, accelerated energy delivery. Patients will undergo monitoring for 1 year, with serial measurements of corneal topography, visual acuity, pachymetry, and visual function.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
8 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Subjects who have one or both eyes that meet criteria 1-4 and also meet at least 1 or more of criteria 5-11 will be considered candidates for this study:
  • •8 years of age or older
  • •Signed written informed consent
  • •Willingness and ability to comply with schedule for follow-up visits
  • •Contact Lens Wearers Only:
  • •Removal of contact lenses for the required period of time prior to the screening refraction:
  • •Contact Lens Type Minimum Discontinuation Time Soft 3 days Soft Extended Wear 3 days Soft Toric 3 days Rigid gas permeable 2 Weeks
  • •Subjects who cannot function without wearing their contact lenses, may forgo discontinuation of contact lenses.
  • •Presence of central or inferior steepening.
  • •Axial topography consistent with keratoconus, post-surgical ectasia, or pellucid marginal degeneration
  • •Presence of one or more findings associated with keratoconus or pellucid marginal degeneration, such as:
  • •Fleischer ring
  • •Vogt's striae
  • •Decentered corneal apex
  • •Munson's sign
  • •Rizzutti's sign
  • •Apical Corneal scarring consistent with Bowman's breaks
  • •Scissoring of the retinoscopic reflex
  • •Crab-claw appearance on topography
  • •Steepest keratometry (Kmax) value ≥ 47.20 D
  • •I-S keratometry difference > 1.5 D on the Pentacam/Orbscan map or topography map
  • •Posterior corneal elevation >16 microns
  • •Thinnest corneal point >300 microns

排除标准

  • 未提供

研究组 & 干预措施

Pulsed 6mW/cm2

Experimental

6mW/cm2, with pulsed mode, 10 seconds on, 10 second off, for 30 minute total treatment time

干预措施: PXL-330 Platinum device for crosslinking with Peschke riboflavin solution (Combination Product)

Pulsed 4mW/cm2

Experimental

4mW/cm2, with pulsed mode, 10 seconds on, 10 second off, for 45 minute total treatment time

干预措施: PXL-330 Platinum device for crosslinking with Peschke riboflavin solution (Combination Product)

结局指标

主要结局

K-Max

时间窗: 12 Months

Change in K-Max, compared to baseline

K-Mean

时间窗: 12 Months

Change in K-Mean, compared to baseline

次要结局

  • Best Corrected Visual Acuity(12 Months)
  • Central Pachymetry(12 Months)
  • Uncorrected Visual Acuity(12 Months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验